Refine
Has Fulltext
- yes (18)
Is part of the Bibliography
- yes (18)
Document Type
- Journal article (11)
- Conference Proceeding (4)
- Preprint (3)
Keywords
- Positronen-Emissions-Tomografie (14)
- PET (9)
- positron emission tomography (6)
- neuroendocrine tumor (5)
- RADS (3)
- SSTR (3)
- ageing (3)
- prostate cancer (3)
- somatostatin receptor (3)
- theranostics (3)
- 11C-HED (2)
- 18F-FDG (2)
- DaTscan (2)
- Ioflupane (2)
- PET/CT (2)
- PSMA (2)
- PSMA-RADS (2)
- Parkinson (2)
- Parkinson Disease (2)
- Parkinson-Krankheit (2)
- SPECT (2)
- [177Lu]-DOTATATE/-DOTATOC (2)
- [68Ga] (2)
- molecular imaging (2)
- personalized medicine (2)
- tumor heterogeneity (2)
- 11C-Hydroxyephedrine (1)
- 18F-DCFPyL (1)
- 18F-FDS (1)
- 18F-LMI1195 (1)
- 2-deoxy-2-(18F)fluoro-D-glucose (1)
- 2-deoxy-2-18F-fluoro-D-sorbitol (1)
- 68Ga-DOTANOC (1)
- 68Ga-DOTATATE (1)
- 68Ga-DOTATOC (1)
- AI (1)
- DCGAN (1)
- Diabetes (1)
- ECG (1)
- ECG-gated (1)
- EKG (1)
- FV45 (1)
- GAN (1)
- MI-RADS (1)
- MRI (1)
- Magnetresonanztomografie (1)
- Myokarditis (1)
- PROMISE (1)
- PRRT (1)
- Pancreas (1)
- Positron-Emission Tomography (1)
- SSTR-PET (1)
- SSTR-RADS (1)
- TKI (1)
- [68Ga]DOTATOC (1)
- angiotensin II type 1 receptor (1)
- artificial intelligence (1)
- cardiac sympathetic nervous system (1)
- diabetische Kardiomyopathie (1)
- heart failure (1)
- hydroxyephedrine (1)
- inflammation (1)
- interobserver (1)
- interreader (1)
- kidney (1)
- machine learning (1)
- magnetic resonance imaging (1)
- medullary thyroid carcinoma (1)
- moycardial sympathetic innervation (1)
- myocardial sympathetic innervation imaging (1)
- myocarditis (1)
- neuroendocrine neoplasia (1)
- pancreas (1)
- peptide receptor radionuclide therapy (1)
- personalized treatment (1)
- phaeochromocytoma (1)
- prostate-specific membrane antigen (1)
- prostate-specific membrane antigen (PSMA) (1)
- quantification (1)
- renal imaging (1)
- renin-angiotensin system (1)
- reporting and data system (1)
- reporting and data systems (1)
- somatostatin receptor (SSTR) (1)
- split renal function (1)
- standardization (1)
- standardized reporting (1)
- storage vesicle turnover (1)
- stroke (1)
- sympathetic nervous system (1)
- tyrosine kinase inhibitor (1)
- valsartan (1)
- vandetanib (1)
Institute
Sonstige beteiligte Institutionen
- Johns Hopkins School of Medicine (18) (remove)
EU-Project number / Contract (GA) number
- 701983 (18)
Purpose: The metabolically most active lesion in 2-deoxy-2-(\(^{18}\)F)fluoro-D-glucose (\(^{18}\)F-FDG) PET/CT can predict progression-free survival (PFS) in patients with medullary thyroid carcinoma (MTC) starting treatment with the tyrosine kinase inhibitor (TKI) vandetanib. However, this metric failed in overall survival (OS) prediction. In the present proof of concept study, we aimed to explore the prognostic value of intratumoral textural features (TF) as well as volumetric parameters (total lesion glycolysis, TLG) derived by pre-therapeutic \(^{18}\)F-FDG PET.
Methods: Eighteen patients with progressive MTC underwent baseline \(^{18}\)F-FDG PET/CT prior to and 3 months after vandetanib initiation. By manual segmentation of the tumor burden at baseline and follow-up PET, intratumoral TF and TLG were computed. The ability of TLG, imaging-based TF, and clinical parameters (including age, tumor marker doubling times, prior therapies and RET (rearranged during transfection) mutational status) for prediction of both PFS and OS were evaluated.
Results: The TF Complexity and the volumetric parameter TLG obtained at baseline prior to TKI initiation successfully differentiated between low- and high-risk patients. Complexity allocated 10/18 patients to the high-risk group with an OS of 3.3y (vs. low-risk group, OS=5.3y, 8/18, AUC=0.78, P=0.03). Baseline TLG designated 11/18 patients to the high-risk group (OS=3.5y vs. low-risk group, OS=5y, 7/18, AUC=0.83, P=0.005). The Hazard Ratio for cancer-related death was 6.1 for Complexity (TLG, 9.5). Among investigated clinical parameters, the age at initiation of TKI treatment reached significance for PFS prediction (P=0.02, OS, n.s.).
Conclusions: The TF Complexity and the volumetric parameter TLG are both independent parameters for OS prediction.